AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

OTCMKTS:LXRPLexaria Bioscience News Headlines

$0.30
+0.00 (+0.10 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.29
Now: $0.30
$0.31
50-Day Range
$0.25
MA: $0.30
$0.39
52-Week Range
$0.22
Now: $0.30
$1.00
Volume41,089 shs
Average Volume110,275 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Lexaria Bioscience (OTCMKTS LXRP) News Headlines

Source:
DateHeadline
Lexaria Bioscience Corp.: Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations ServicesLexaria Bioscience Corp.: Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services
www.finanznachrichten.de - June 1 at 6:37 PM
Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations ServicesLexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services
finance.yahoo.com - June 1 at 6:37 PM
Lexaria Bioscience Corp.: Lexaria Bioscience Confirms Closing of US$2,039,228 Private PlacementLexaria Bioscience Corp.: Lexaria Bioscience Confirms Closing of US$2,039,228 Private Placement
www.finanznachrichten.de - May 11 at 9:15 PM
Lexaria Bioscience Confirms Closing of US$2,039,228 Private PlacementLexaria Bioscience Confirms Closing of US$2,039,228 Private Placement
finance.yahoo.com - May 11 at 9:15 PM
Lexaria Bioscience Confirms More Than $2M Private Placement DealLexaria Bioscience Confirms More Than $2M Private Placement Deal
www.benzinga.com - May 5 at 2:49 AM
lexaria biosciencelexaria bioscience
www.benzinga.com - May 4 at 9:49 PM
Lexaria Bio launches over $2M private placementLexaria Bio launches over $2M private placement
seekingalpha.com - May 4 at 4:15 PM
Lexaria Receives Notice of Allowance for New Patent and Awards Stock OptionsLexaria Receives Notice of Allowance for New Patent and Awards Stock Options
finance.yahoo.com - April 23 at 7:40 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19Lexaria Bioscience Corp.: Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19
www.finanznachrichten.de - April 21 at 7:32 AM
Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19
finance.yahoo.com - April 21 at 7:32 AM
Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26
www.benzinga.com - March 24 at 7:35 PM
Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020
finance.yahoo.com - March 24 at 8:58 AM
Lexaria jumps on coronavirus bandwagonLexaria jumps on coronavirus bandwagon
seekingalpha.com - March 23 at 9:09 AM
Lexaria Bio begins COVID-19 drug delivery programLexaria Bio begins COVID-19 drug delivery program
seekingalpha.com - March 19 at 7:29 AM
Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery ProgramLexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program
finance.yahoo.com - March 19 at 7:29 AM
Lexaria Bioscience Corp.: Lexaria Provides Update on Two Licensed ClientsLexaria Bioscience Corp.: Lexaria Provides Update on Two Licensed Clients
www.finanznachrichten.de - March 4 at 2:49 PM
Lexaria Provides Update on Two Licensed ClientsLexaria Provides Update on Two Licensed Clients
finance.yahoo.com - March 4 at 2:49 PM
Lexaria Bioscience Corp.: Industry Solutions from Lexarias DehydraTECHTM Hemp and Cannabis PowdersLexaria Bioscience Corp.: Industry Solutions from Lexaria's DehydraTECHTM Hemp and Cannabis Powders
www.finanznachrichten.de - February 13 at 7:32 AM
Industry Solutions from Lexaria’s DehydraTECHTM Hemp and Cannabis PowdersIndustry Solutions from Lexaria’s DehydraTECHTM Hemp and Cannabis Powders
finance.yahoo.com - February 13 at 7:32 AM
Lexaria Bio teams up with Cannadips for CBD oral pouch & dip categoryLexaria Bio teams up with Cannadips for CBD oral pouch & dip category
seekingalpha.com - January 14 at 4:11 PM
Lexaria Provides Strategic Update from CEOLexaria Provides Strategic Update from CEO
finance.yahoo.com - January 9 at 4:43 PM
Lexaria Bioscience Corp.: Lexarias Technology Now Works in Less Than 10 MinutesLexaria Bioscience Corp.: Lexaria's Technology Now Works in Less Than 10 Minutes
www.finanznachrichten.de - November 21 at 7:59 AM
Lexaria’s Technology Now Works in Less Than 10 MinutesLexaria’s Technology Now Works in Less Than 10 Minutes
finance.yahoo.com - November 21 at 7:59 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Appoints Gregg Smith as Senior AdvisorLexaria Bioscience Corp.: Lexaria Bioscience Appoints Gregg Smith as Senior Advisor
www.finanznachrichten.de - November 5 at 5:57 PM
Lexaria Bioscience Appoints Gregg Smith as Senior AdvisorLexaria Bioscience Appoints Gregg Smith as Senior Advisor
finance.yahoo.com - November 5 at 7:56 AM
Lexaria Applauds FDA Decision on Reduced Risk Tobacco FormatLexaria Applauds FDA Decision on Reduced Risk Tobacco Format
finance.yahoo.com - October 24 at 9:19 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with AltriaLexaria Bioscience Corp.: Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
www.finanznachrichten.de - October 8 at 7:18 AM
Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with AltriaLexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
finance.yahoo.com - October 8 at 7:18 AM
Lexaria Bioscience Corp.: Peer Reviewed Clinical Journal Publishes Lexaria Biosciences Human CBD Study ResultsLexaria Bioscience Corp.: Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results
www.finanznachrichten.de - September 17 at 8:04 AM
Peer Reviewed Clinical Journal Publishes Lexaria Biosciences Human CBD Study ResultsPeer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results
finance.yahoo.com - September 17 at 8:04 AM
Lexaria Bio nabs new Australian patentLexaria Bio nabs new Australian patent
seekingalpha.com - August 27 at 7:54 AM
Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease ConditionsLexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions
finance.yahoo.com - August 27 at 7:54 AM
Lexaria launches advanced hemp oilLexaria launches advanced hemp oil
seekingalpha.com - August 21 at 11:19 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Announces it has Received Four New PatentsLexaria Bioscience Corp.: Lexaria Bioscience Announces it has Received Four New Patents
www.finanznachrichten.de - August 15 at 9:27 AM
Lexaria Bioscience Announces it has Received Four New PatentsLexaria Bioscience Announces it has Received Four New Patents
finance.yahoo.com - August 15 at 9:27 AM
More Companies Lining Up to Get Their Hands on Lexarias DehydraTECH Platform -- CFN MediaMore Companies Lining Up to Get Their Hands on Lexarias DehydraTECH Platform -- CFN Media
finance.yahoo.com - August 15 at 9:27 AM
NetworkNewsBreaks - Lexaria Bioscience Corp. (LXX) (otcqx:LXRP) Appoints Consumer Packaged Goods Veteran to Board of DirectorsNetworkNewsBreaks - Lexaria Bioscience Corp. (LXX) (otcqx:LXRP) Appoints Consumer Packaged Goods Veteran to Board of Directors
www.marketwatch.com - August 14 at 3:26 PM
Lexaria Bioscience Corp.: Lexarias Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of DirectorsLexaria Bioscience Corp.: Lexaria's Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors
www.finanznachrichten.de - August 14 at 11:32 AM
Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of DirectorsLexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors
finance.yahoo.com - August 14 at 11:32 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Receives Cannabis R&D License from Health CanadaLexaria Bioscience Corp.: Lexaria Bioscience Receives Cannabis R&D License from Health Canada
www.finanznachrichten.de - August 13 at 10:06 AM
Health Canada grants cannabis R&D license to Lexaria CanPharmHealth Canada grants cannabis R&D license to Lexaria CanPharm
seekingalpha.com - August 13 at 10:06 AM
Lexaria Bioscience Receives Cannabis R&D License from Health CanadaLexaria Bioscience Receives Cannabis R&D License from Health Canada
finance.yahoo.com - August 13 at 10:06 AM
Lexaria Bioscience Completes Initial Project with Canada’s National Research CouncilLexaria Bioscience Completes Initial Project with Canada’s National Research Council
finance.yahoo.com - August 8 at 11:34 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Engages Integra Consulting Group to Provide Investor Relations ServicesLexaria Bioscience Corp.: Lexaria Bioscience Engages Integra Consulting Group to Provide Investor Relations Services
www.finanznachrichten.de - August 2 at 9:15 AM
Lexaria Bioscience Engages Integra Consulting Group to Provide Investor Relations ServicesLexaria Bioscience Engages Integra Consulting Group to Provide Investor Relations Services
finance.yahoo.com - August 2 at 9:15 AM
Lexaria Bioscience Corp.: Lexaria Bioscience Enters CBD License Agreement with Universal HempLexaria Bioscience Corp.: Lexaria Bioscience Enters CBD License Agreement with Universal Hemp
www.finanznachrichten.de - July 11 at 8:20 AM
Lexaria Bioscience inks deal for CBD-based food ingredientsLexaria Bioscience inks deal for CBD-based food ingredients
seekingalpha.com - July 11 at 8:20 AM
Lexaria Bioscience Enters CBD License Agreement with Universal HempLexaria Bioscience Enters CBD License Agreement with Universal Hemp
finance.yahoo.com - July 11 at 8:20 AM
Lexaria Bio inks deal for CBD-based beverageLexaria Bio inks deal for CBD-based beverage
seekingalpha.com - July 10 at 8:50 AM
Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s BeveragesLexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages
finance.yahoo.com - July 10 at 8:50 AM
This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.